Sugars, particularly glucose, are a primary energy source for cells, including cancer cells. The metabolism of glucose in cancer cells is often altered, a phenomenon known as the Warburg Effect. This means that cancer cells consume glucose at much higher rates than normal cells, even in the presence of adequate oxygen levels. Understanding this metabolic reprogramming is crucial for developing targeted therapies.
